Moreover, the number of plasma samples with a concentration of IL-26 above the lower limit of detection (LLOD) increased from 10% in samples from healthy controls and patients with mild COVID-19, to 30 and 55% in samples from patients with moderate and severe/critical COVID-19, respectively (Figure 1B). The gene discussed is IL26; the disease is COVID-19.